Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Daniel on +441494 818 028 or Daniel@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Daniel Newbury
Senior Account Manager
Daniel@zenopa.com
+441494 818 028

Testimonials
I couldn't speak any more highly of my experience with Zenopa. As a graduate wanting to break into the healthcare industry from day one they understood my individual aspirations and tailored the recru...
Anna-Sophia, 2012

Quintiles launches digital patient unit

4 January 2012 00:00 in Marketing Services


Quintiles has announced the launch of its digital patient unit, a new organisation that aims to provide patients with information on personal health management.

The unit combines the biopharmaceutical services provider's online communities and digital expertise to provide people with more opportunities to participate in clinical research, observational studies and other programmes that can help in the management of various conditions.

Central to the new offering is the company's existing patient communities at MediGuard.com and ClinicalResearch.com, which provide members with guidance on drug safety issues and the availability of local trials.

David Coman, senior vice-president at Quintiles and head of the new digital patient unit, said this move reflects the fact that people are increasingly likely to use the internet as a resource to find out more about their health.

"We will be better able to ... provide our customers with a more efficient channel to find the appropriate people who may be interested in participating in clinical, observational or disease management programmes," he said.

Last month, the company announced a new partnership with drugmaker Intarcia Therapeutics pertaining to the development of a new therapy for diabetes.ADNFCR-8000103-ID-801255166-ADNFCR

Other news stories from 04/01/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd